Fig. 4

Association of PANII with immunotherapy outcome. (A-C) Differences in common immune checkpoint expression between patients in high/low PANII groups in KIRC, KIRP, and KICH. Differences in TMB levels (D-F) and MSI levels (G-I) between patients in high/low PANII groups in KIRC, KIRP, and KICH. (J-L) Differences in TIDE and Exclusion levels between patients in high/low PANII groups in KIRC, KIRP and KICH. (M-O) IPS scores for anti-PD1(-)CTLA4(-), anti-PD1(+)CTLA4(-), anti-PD1(-)CTLA4(+), and anti-PD1(+)CTLA4(+) blocker ground IPS scores for the high and low PANII groups in KIRC, KIRP, and KICH